Suchergebnisse - "Mwandumba, Henry C"

PubPharm (6)

1

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa : an economic analysis of the AMBITION-cm trial

enthalten in: The Lancet. Global health | 2022

von Lawrence, D. | Muthoga, C. | Meya, D. | +133

CommentIn: Lancet Glob Health. 2022 Dec;10(12):e1688. - PMID 36400070

2

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis

enthalten in: The New England journal of medicine | 2022

von Jarvis, J. | Lawrence, D. | Meya, D. | +140

CommentIn: N Engl J Med. 2022 Mar 24;386(12):1179-1181. - PMID 35320648

3

Cryptococcal meningoencephalitis : time for action

enthalten in: The Lancet. Infectious diseases | 2021

von Stott, K. | Loyse, A. | Jarvis, J. | +8

4

AMBIsome Therapy Induction OptimisatioN (AMBITION) : High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2018

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26

ErratumIn: Trials. 2019 Jan 14;20(1):48. - PMID 30642386

5

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2018

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26

6

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

enthalten in: Trials | 2018

von Lawrence, D. | Youssouf, N. | Molloy, S. | +26

1
[1]